Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alvotech - Ordinary Shares (NQ:ALVO)

7.650 -0.190 (-2.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Alvotech - Ordinary Shares

< Previous 1 2 3 Next >
This Johnson & Johnson Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
 
Via Benzinga
Soho House, GoodRx Holdings, Dayforce And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
Alvotech SA (NASDAQ:ALVO) Surpasses Q2 2025 Estimates with Strong Revenue and EPS Growth
Alvotech SA (NASDAQ:ALVO) reported strong Q2 2025 earnings, beating revenue and EPS estimates with 41% growth. Shares surged 8.5% post-announcement. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Alvotech's Earnings: A Preview
 
Via Benzinga
Earnings Scheduled For May 7, 2025
 
Via Benzinga
Alvotech's Earnings Outlook
 
Via Benzinga
Earnings Scheduled For November 13, 2024
 
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Wednesday?
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
Why Is Alvotech Stock Trading Higher On Wednesday?
Alvotech acquires Swiss packaging firm Ivers-Lee to boost biosimilar production capacity ahead of three 2025 launches. 
Via Benzinga
Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug
Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives. 
Via Benzinga
Why Is Teva Stock Trading Higher On Tuesday?
Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic Design. 
Via Benzinga
Alvotech's Earnings Outlook
 
Via Benzinga
ALVO Stock Earnings: Alvotech Misses Revenue for Q2 2024
ALVO stock results show that Alvotech missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For August 13, 2025
 
Via Benzinga
Groupon Posts Upbeat Earnings, Joins Axon Enterprise, Warner Bros. Discovery, MercadoLibre And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?
FDA approves Teva and Alvotech's Selarsdi as an interchangeable biosimilar to Stelara, supporting the treatment of multiple chronic inflammatory diseases. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Earnings Scheduled For March 26, 2025
 
Via Benzinga
Alvotech Strengthens Biosimilar Portfolio With $27 Million Xbrane R&D Deal
Alvotech acquires Xbrane's R&D operations and biosimilar candidate for SEK 275 million, enhancing development capabilities and expanding into Sweden. 
Via Benzinga
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
JB Hunt Transport Posts Weak Earnings, Joins JetBlue Airways And Other Big Stocks Moving Lower In Friday's Pre-Market Session
 
Via Benzinga
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs. 
Via Benzinga
Vipshop, Hesai Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
ALVO Stock Earnings: Alvotech Misses EPS for Q1 2024
ALVO stock results show that Alvotech missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Stocks Hold Steady On Mixed Fed Remarks, First Solar Rallies, Bitcoin Falls Below $70,000: What's Driving Markets Tuesday?
It’s a rather quiet session on Tuesday, with major U.S. averages trading around the flatline at midday trading in New York. 
Via Benzinga
Topics Economy
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.